RAIN - Rain Therapeutics Inc. (RAIN) CEO Avanish Vellanki On Q3 2021 Results - Earnings Call Transcript
Rain Therapeutics, Inc.(RAIN) Q3 2021 Earnings Conference Call November 10, 2021 4:30 PM ET Company Participants Glenn Garmont - LifeSci Advisors, Investor Relations Avanish Vellanki - Chief Executive Officer Richard Bryce - Chief Medical Officer Robert Doebele - Chief Scientific Officer Nelson Cabatuan - Senior Vice President, Finance Conference Call Participants Yigal Nochomovitz - Citigroup Joe Catanzaro - Piper Sandler Graig Suvannavejh - Goldman Sachs Disclaimer*: This transcript is designed to be used alongside the freely available audio recording on this page. Timestamps within the transcript are designed to help you navigate the audio should the corresponding text be unclear. The machine-assisted output provided is partly edited and is designed as a guide. Presentation Operator 00:05 Thank you for standing by, and welcome to the Rain Therapeutics Third Quarter twenty twenty one Financial Results Conference Call. At this time, all participants are in a listen-only mode. After the speakers presentation,
For further details see:
Rain Therapeutics, Inc. (RAIN) CEO Avanish Vellanki On Q3 2021 Results - Earnings Call Transcript